These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, Osterhoff G, Ugurel S, Utikal J, von Bubnoff D, Weishaupt C, Grabbe S. J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104 [Abstract] [Full Text] [Related]
6. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome. Hanlon A, Stasko T, Christiansen D, Cyrus N, Galan A. Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637 [Abstract] [Full Text] [Related]
7. [Atypical fibroxanthoma and pleomorphic dermal sarcoma]. Ziemer M, Jäger IM, Dippel E. Hautarzt; 2019 Sep; 70(9):661-669. PubMed ID: 31468069 [Abstract] [Full Text] [Related]
13. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma. Anders IM, Schimmelpfennig C, Wiedemann K, Löffler D, Kämpf C, Blumert C, Reiche K, Kunz M, Anderegg U, Simon JC, Ziemer M. J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902 [Abstract] [Full Text] [Related]
14. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis. Ørholt M, Abebe K, Aaberg F, Rasmussen LE, Daugaard S, Loya AC, Herly M, Vester-Glowinski PV. Am J Dermatopathol; 2022 Dec 01; 44(12):913-920. PubMed ID: 36395448 [Abstract] [Full Text] [Related]